Refine by
Myeloid Leukemia Services Available In Cyprus
5 services found
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
NOMO-1 established from the bone marrow of a 31-year-old woman with acute myeloid leukemia (AML FAB M5a) at 2nd relapse; described to show strong lysozyme activity in the cytoplasm, phagocytic activities, and cells are responsive to induction of differentiation with TPA; cells carry the t(9;11)(q23;p22) MLL-MLLT3 (MLL-AF9) alteration ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Cytarabine Hydrochloride: Cytarabine hydrochloride is a white to off-white crystalline with the chemical name 1-β-D-arabinofuranosyl-4-amino-2(1H)-pyrimidinone hydrochloride. Cytarabine hydrochloride is used in chemotherapy for white blood cell cancers, especially acute myeloid leukemia (AML). ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Ancitabine hydrochloride is the hydrochloride salt of a cytarabine congener prodrug, so it has similar antineoplastic activity to cytarabine. It is widely used in chemotherapy for treating white blood cell cancers, especially acute myeloid leukemia (AML). ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and optimized to ...
by:Base Pair Biotechnologies, Inc. based inPearland, TEXAS (USA)
Aptamer discovery is a complex process. Customized libraries and selection techniques are employed to achieve selective binding to a target of interest under anticipated conditions. In some cases, selected aptamers may not quite achieve the degree of affinity or stability required for a specific end-use application. In addition, aptamer modification for immobilization or signal generation is ...